CN Patent

CN1202829C — 药用制剂

Assigned to Gilead Sciences Inc · Expires 2005-05-25 · 21y expired

What this patent protects

本发明提供了一类组合物，它含有核苷酸类似物9-[2-[[二[(新戊酰氧基)甲基]膦酰基]甲氧基]乙基]腺嘌呤和碱性赋形剂，可以有或没有L-肉毒碱-L-酒石酸盐。该组合物比以前所述的那些更稳定。本发明还提供了制备这些组合物及其中间体的方法。

USPTO Abstract

本发明提供了一类组合物，它含有核苷酸类似物9-[2-[[二[(新戊酰氧基)甲基]膦酰基]甲氧基]乙基]腺嘌呤和碱性赋形剂，可以有或没有L-肉毒碱-L-酒石酸盐。该组合物比以前所述的那些更稳定。本发明还提供了制备这些组合物及其中间体的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1202829C
Jurisdiction
CN
Classification
—
Expires
2005-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.